These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 30110705)

  • 1. The Progression of the Stargardt Disease Type 4 (ProgStar-4) Study: Design and Baseline Characteristics (ProgStar-4 Report No. 1).
    Strauss RW; Muñoz B; Ahmed MI; Bittencourt M; Schönbach EM; Michaelides M; Birch D; Zrenner E; Ervin AM; Charbel Issa P; Kong J; Wolfson Y; Shah M; Bagheri S; West S; Scholl HPN;
    Ophthalmic Res; 2018; 60(3):185-194. PubMed ID: 30110705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies: Design and Baseline Characteristics: ProgStar Report No. 1.
    Strauss RW; Ho A; Muñoz B; Cideciyan AV; Sahel JA; Sunness JS; Birch DG; Bernstein PS; Michaelides M; Traboulsi EI; Zrenner E; Sadda S; Ervin AM; West S; Scholl HP;
    Ophthalmology; 2016 Apr; 123(4):817-28. PubMed ID: 26786511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of Stargardt Disease as Determined by Fundus Autofluorescence in the Retrospective Progression of Stargardt Disease Study (ProgStar Report No. 9).
    Strauss RW; Muñoz B; Ho A; Jha A; Michaelides M; Cideciyan AV; Audo I; Birch DG; Hariri AH; Nittala MG; Sadda S; West S; Scholl HPN;
    JAMA Ophthalmol; 2017 Nov; 135(11):1232-1241. PubMed ID: 29049437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of Atrophic Lesions in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 5.
    Strauss RW; Muñoz B; Ho A; Jha A; Michaelides M; Mohand-Said S; Cideciyan AV; Birch D; Hariri AH; Nittala MG; Sadda S; Scholl HPN;
    JAMA Ophthalmol; 2017 Jul; 135(7):687-695. PubMed ID: 28542697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macular Sensitivity Measured With Microperimetry in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 7.
    Schönbach EM; Wolfson Y; Strauss RW; Ibrahim MA; Kong X; Muñoz B; Birch DG; Cideciyan AV; Hahn GA; Nittala M; Sunness JS; Sadda SR; West SK; Scholl HPN;
    JAMA Ophthalmol; 2017 Jul; 135(7):696-703. PubMed ID: 28542693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scotopic Microperimetric Assessment of Rod Function in Stargardt Disease (SMART) Study: Design and Baseline Characteristics (Report No. 1).
    Strauss RW; Kong X; Bittencourt MG; Ho A; Jha A; Schönbach EM; Ahmed MI; Muñoz B; Ervin AM; Michaelides M; Birch DG; Sahel JA; Sunness JS; Zrenner E; Bagheri S; Ip M; Sadda S; West S; Scholl HPN;
    Ophthalmic Res; 2019; 61(1):36-43. PubMed ID: 29940588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual Acuity Change over 12 Months in the Prospective Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: ProgStar Report Number 6.
    Kong X; Strauss RW; Cideciyan AV; Michaelides M; Sahel JA; Munoz B; Ahmed M; Ervin AM; West SK; Cheetham JK; Scholl HPN;
    Ophthalmology; 2017 Nov; 124(11):1640-1651. PubMed ID: 28549516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of Stargardt Disease as Determined by Fundus Autofluorescence Over a 24-Month Period (ProgStar Report No. 17).
    Strauss RW; Ho A; Jha A; Fujinami K; Michaelides M; Cideciyan AV; Audo I; Birch DG; Sadda S; Ip M; West S; Schönbach EM; Kong X; Scholl HPN;
    Am J Ophthalmol; 2023 Jun; 250():157-170. PubMed ID: 36764427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal Microperimetric Changes of Macular Sensitivity in Stargardt Disease After 12 Months: ProgStar Report No. 13.
    Schönbach EM; Strauss RW; Muñoz B; Wolfson Y; Ibrahim MA; Birch DG; Zrenner E; Sunness JS; Ip MS; Sadda SR; West SK; Scholl HPN;
    JAMA Ophthalmol; 2020 Jul; 138(7):772-779. PubMed ID: 32463436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of Stargardt Disease as Determined by Fundus Autofluorescence Over a 12-Month Period: ProgStar Report No. 11.
    Strauss RW; Kong X; Ho A; Jha A; West S; Ip M; Bernstein PS; Birch DG; Cideciyan AV; Michaelides M; Sahel JA; Sunness JS; Traboulsi EI; Zrenner E; Pitetta S; Jenkins D; Hariri AH; Sadda S; Scholl HPN;
    JAMA Ophthalmol; 2019 Oct; 137(10):1134-1145. PubMed ID: 31369039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microperimetry, fundus autofluorescence, and retinal layer changes in progressing geographic atrophy.
    Pilotto E; Benetti E; Convento E; Guidolin F; Longhin E; Parrozzani R; Midena E
    Can J Ophthalmol; 2013 Oct; 48(5):386-93. PubMed ID: 24093185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation.
    Vujosevic S; Bottega E; Casciano M; Pilotto E; Convento E; Midena E
    Retina; 2010 Jun; 30(6):908-16. PubMed ID: 20168272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microperimetric correlations of autofluorescence and optical coherence tomography imaging in dry age-related macular degeneration.
    Querques L; Querques G; Forte R; Souied EH
    Am J Ophthalmol; 2012 Jun; 153(6):1110-5. PubMed ID: 22321805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual Acuity Change Over 24 Months and Its Association With Foveal Phenotype and Genotype in Individuals With Stargardt Disease: ProgStar Study Report No. 10.
    Kong X; Fujinami K; Strauss RW; Munoz B; West SK; Cideciyan AV; Michaelides M; Ahmed M; Ervin AM; Schönbach E; Cheetham JK; Scholl HPN;
    JAMA Ophthalmol; 2018 Aug; 136(8):920-928. PubMed ID: 29902293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal Changes of Fixation Location and Stability Within 12 Months in Stargardt Disease: ProgStar Report No. 12.
    Schönbach EM; Strauss RW; Kong X; Muñoz B; Ibrahim MA; Sunness JS; Birch DG; Hahn GA; Nasser F; Zrenner E; Sadda SR; West SK; Scholl HPN;
    Am J Ophthalmol; 2018 Sep; 193():54-61. PubMed ID: 29890160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term longitudinal modifications in mesopic microperimetry in early and intermediate age-related macular degeneration.
    Vujosevic S; Pucci P; Casciano M; Longhin E; Convento E; Bini S; Midena E
    Graefes Arch Clin Exp Ophthalmol; 2017 Feb; 255(2):301-309. PubMed ID: 27582087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Progression of Stargardt Disease Using Volumetric Hill of Vision Analyses Over 24 Months: ProgStar Report No.15.
    Schönbach EM; Janeschitz-Kriegl L; Strauss RW; Cattaneo MEGV; Fujinami K; Birch DG; Cideciyan AV; Sunness JS; Weleber RG; Ip MS; Sadda SR; Scholl HPN;
    Am J Ophthalmol; 2021 Oct; 230():123-133. PubMed ID: 33951446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic macular edema: fundus autofluorescence and functional correlations.
    Vujosevic S; Casciano M; Pilotto E; Boccassini B; Varano M; Midena E
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):442-8. PubMed ID: 20720226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between fundus autofluorescence and central visual function in chronic central serous chorioretinopathy.
    Eandi CM; Piccolino FC; Alovisi C; Tridico F; Giacomello D; Grignolo FM
    Am J Ophthalmol; 2015 Apr; 159(4):652-8. PubMed ID: 25555802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Faster Sensitivity Loss around Dense Scotomas than for Overall Macular Sensitivity in Stargardt Disease: ProgStar Report No. 14.
    Schönbach EM; Strauss RW; Ibrahim MA; Janes JL; Birch DG; Cideciyan AV; Sunness JS; Muñoz B; Ip MS; Sadda SR; Scholl HPN;
    Am J Ophthalmol; 2020 Aug; 216():219-225. PubMed ID: 32222369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.